| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 46.95B | 48.87B | 46.59B | 45.38B | 43.60B | 40.34B |
| Gross Profit | 5.40B | 6.11B | 5.44B | 5.94B | 5.03B | 4.65B |
| EBITDA | 3.15B | 4.17B | 3.22B | 3.91B | 3.35B | 4.65B |
| Net Income | 645.00M | 1.28B | 1.36B | 1.16B | 793.00M | 1.54B |
Balance Sheet | ||||||
| Total Assets | 40.27B | 42.28B | 41.15B | 41.63B | 42.56B | 44.78B |
| Cash, Cash Equivalents and Short-Term Investments | 4.75B | 6.36B | 5.38B | 7.39B | 8.00B | 9.21B |
| Total Debt | 4.63B | 4.56B | 4.95B | 6.53B | 8.77B | 11.18B |
| Total Liabilities | 14.73B | 15.67B | 15.31B | 16.80B | 18.66B | 21.23B |
| Stockholders Equity | 25.54B | 26.61B | 25.84B | 24.82B | 23.89B | 23.53B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 1.70B | 263.00M | 2.07B | 1.59B | 5.89B |
| Operating Cash Flow | 0.00 | 3.47B | 2.06B | 3.12B | 2.10B | 6.32B |
| Investing Cash Flow | 0.00 | -1.54B | -1.95B | -1.18B | -346.00M | -482.00M |
| Financing Cash Flow | 0.00 | -947.00M | -2.19B | -2.58B | -3.01B | -2.65B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
76 Outperform | ¥78.34B | 16.01 | ― | 2.22% | 7.41% | 14.31% | |
65 Neutral | ¥1.93B | -16.98 | ― | 3.75% | 1.90% | 19.71% | |
64 Neutral | ¥25.87B | 28.87 | ― | 1.85% | 4.87% | -5.52% | |
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% | |
61 Neutral | ¥248.33B | 12.92 | ― | 1.51% | ― | ― | |
60 Neutral | ¥15.16B | 16.44 | ― | ― | 7.14% | 19.34% |